Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This case describes the management of a patient admitted to an emergency department with general malaise, who deteriorated into cardiac arrest and refractory to advanced life support measures. After extracorporeal cardiopulmonary resuscitation (eCPR) with veno-arterial extracorporeal membrane oxygenation in association with an Impella 2.5 device, the patient underwent cardiac surgery (tissue aortic valve replacement, coronary artery bypass grafting and implantation of short-term paracorporeal left ventricular assist device). Subsequently a long-term LVAD was implanted and the patient was successfully discharged shortly afterwards. This report illustrates the challenges of 'clinical decision making' in a complex patient utilising a wide range of left ventricular support mechanical devices with varying degrees of invasiveness, whilst also reflecting on the current financial and economic considerations in utilizing this type of care pathway.

Original publication




Journal article


Cardiovasc Revasc Med

Publication Date





447 - 449


Extracorporeal membrane oxygenation (ECMO), Impella, Percutaneous ventricular assist device, Refractory cardiac arrest, Ventricular assist device (VAD), Cardiopulmonary Resuscitation, Extracorporeal Membrane Oxygenation, Heart Arrest, Heart Failure, Heart Ventricles, Heart-Assist Devices, Humans, Male, Middle Aged, Treatment Outcome